Skip Navigation U.S. Department of Health and Human Services www.hhs.gov/
Agency for Healthcare Research Quality www.ahrq.gov
www.ahrq.gov/
2008 National Healthcare Quality & Disparities Reports

Table 5_2_3.2a
Adult patients with HIV and CD4 count <50 who received Mycobacterium avium complex (MAC) prophylaxis,a by race/ethnicity, United States, 2005
Population group Total Non-Hispanic, White Non-Hispanic, Black Hispanic Other
Percent SE Percent SE Percent SE Percent SE Percent SE
Total 87.1 1.1 83.4 2.7 87.2 1.4 90.4 2.3 * *
Age 18–44 86.1 1.4 79.4 3.5 86.3 1.8 92.7 2.4 * *
45 and over 89.3 1.8 92.9 3.5 89.0 2.3 84.1 5.6 * *
Gender Male 87.7 1.3 83.3 2.9 88.1 1.7 92.2 2.5 * *
Female 85.3 2.3 * * 84.9 2.7 87.0 5.0 * *
Health insurance Private 90.4 3.5 * * 91.3 4.2 * * * *
Medicaid/dual eligible 88.7 1.7 84.1 5.6 88.2 2.1 92.6 3.2 * *
Medicare 81.5 3.2 75.0 6.3 84.9 4.2 * * * *
Other/uninsured 88.1 2.6 83.3 5.8 87.7 3.7 94.3 4.0 * *

a For HIV patients having at least two CD4 tests < 50 during the year.

* - Data do not meet the criteria for statistical reliability, data quality, or confidentiality.

Key: MAC: Mycobacterium avium complex; SE: standard error.

Source: Agency for Healthcare Research and Quality, Center for Delivery, Organization and Markets, HIV Research Network.

 

AHRQAdvancing Excellence in Health Care